Industry: Machinery & Equipment
Published Date: 2024-01-09
Pages: 117 Pages
Report ld: 3025051
Request Sample
Customized Report
Haemostasis analyzers are instruments assisting the medical practitioners for treating patients with bleeding disorder or blood clotting.
The global market for Haemostasis Analyzers was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Haemostasis Analyzers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Haemostasis Analyzers by region & country, by Type, and by Application.
The Haemostasis Analyzers market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemostasis Analyzers.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Haemostasis Analyzers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Haemostasis Analyzers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Haemostasis Analyzers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Haemostasis Analyzers Product Introduction
1.2 Global Haemostasis Analyzers Market Size Forecast
1.2.1 Global Haemostasis Analyzers Sales Value (2019-2030)
1.2.2 Global Haemostasis Analyzers Sales Volume (2019-2030)
1.2.3 Global Haemostasis Analyzers Sales Price (2019-2030)
1.3 Haemostasis Analyzers Market Trends & Drivers
1.3.1 Haemostasis Analyzers Industry Trends
1.3.2 Haemostasis Analyzers Market Drivers & Opportunity
1.3.3 Haemostasis Analyzers Market Challenges
1.3.4 Haemostasis Analyzers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Haemostasis Analyzers Players Revenue Ranking (2023)
2.2 Global Haemostasis Analyzers Revenue by Company (2019-2024)
2.3 Global Haemostasis Analyzers Players Sales Volume Ranking (2023)
2.4 Global Haemostasis Analyzers Sales Volume by Company Players (2019-2024)
2.5 Global Haemostasis Analyzers Average Price by Company (2019-2024)
2.6 Key Manufacturers Haemostasis Analyzers Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Haemostasis Analyzers Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Haemostasis Analyzers
2.9 Haemostasis Analyzers Market Competitive Analysis
2.9.1 Haemostasis Analyzers Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Haemostasis Analyzers Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostasis Analyzers as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fully Automated Haemostasis Analyzers
3.1.2 Semi-automated Haemostasis Analyzers
3.2 Global Haemostasis Analyzers Sales Value by Type
3.2.1 Global Haemostasis Analyzers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Haemostasis Analyzers Sales Value, by Type (2019-2030)
3.2.3 Global Haemostasis Analyzers Sales Value, by Type (%) (2019-2030)
3.3 Global Haemostasis Analyzers Sales Volume by Type
3.3.1 Global Haemostasis Analyzers Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Haemostasis Analyzers Sales Volume, by Type (2019-2030)
3.3.3 Global Haemostasis Analyzers Sales Volume, by Type (%) (2019-2030)
3.4 Global Haemostasis Analyzers Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Research Institutes
4.1.3 Others
4.2 Global Haemostasis Analyzers Sales Value by Application
4.2.1 Global Haemostasis Analyzers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Haemostasis Analyzers Sales Value, by Application (2019-2030)
4.2.3 Global Haemostasis Analyzers Sales Value, by Application (%) (2019-2030)
4.3 Global Haemostasis Analyzers Sales Volume by Application
4.3.1 Global Haemostasis Analyzers Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Haemostasis Analyzers Sales Volume, by Application (2019-2030)
4.3.3 Global Haemostasis Analyzers Sales Volume, by Application (%) (2019-2030)
4.4 Global Haemostasis Analyzers Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Haemostasis Analyzers Sales Value by Region
5.1.1 Global Haemostasis Analyzers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Haemostasis Analyzers Sales Value by Region (2019-2024)
5.1.3 Global Haemostasis Analyzers Sales Value by Region (2025-2030)
5.1.4 Global Haemostasis Analyzers Sales Value by Region (%), (2019-2030)
5.2 Global Haemostasis Analyzers Sales Volume by Region
5.2.1 Global Haemostasis Analyzers Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Haemostasis Analyzers Sales Volume by Region (2019-2024)
5.2.3 Global Haemostasis Analyzers Sales Volume by Region (2025-2030)
5.2.4 Global Haemostasis Analyzers Sales Volume by Region (%), (2019-2030)
5.3 Global Haemostasis Analyzers Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Haemostasis Analyzers Sales Value, 2019-2030
5.4.2 North America Haemostasis Analyzers Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Haemostasis Analyzers Sales Value, 2019-2030
5.5.2 Europe Haemostasis Analyzers Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Haemostasis Analyzers Sales Value, 2019-2030
5.6.2 Asia Pacific Haemostasis Analyzers Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Haemostasis Analyzers Sales Value, 2019-2030
5.7.2 South America Haemostasis Analyzers Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Haemostasis Analyzers Sales Value, 2019-2030
5.8.2 Middle East & Africa Haemostasis Analyzers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Haemostasis Analyzers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Haemostasis Analyzers Sales Value
6.2.1 Key Countries/Regions Haemostasis Analyzers Sales Value, 2019-2030
6.2.2 Key Countries/Regions Haemostasis Analyzers Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Haemostasis Analyzers Sales Value, 2019-2030
6.3.2 United States Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Haemostasis Analyzers Sales Value, 2019-2030
6.4.2 Europe Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Haemostasis Analyzers Sales Value, 2019-2030
6.5.2 China Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Haemostasis Analyzers Sales Value, 2019-2030
6.6.2 Japan Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Haemostasis Analyzers Sales Value, 2019-2030
6.7.2 South Korea Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Haemostasis Analyzers Sales Value, 2019-2030
6.8.2 Southeast Asia Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Haemostasis Analyzers Sales Value, 2019-2030
6.9.2 India Haemostasis Analyzers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Haemostasis Analyzers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Stago Group (HemoSonics)
7.1.1 Stago Group (HemoSonics) Company Information
7.1.2 Stago Group (HemoSonics) Introduction and Business Overview
7.1.3 Stago Group (HemoSonics) Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Stago Group (HemoSonics) Haemostasis Analyzers Product Offerings
7.1.5 Stago Group (HemoSonics) Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Introduction and Business Overview
7.2.3 Grifols Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Grifols Haemostasis Analyzers Product Offerings
7.2.5 Grifols Recent Development
7.3 Haemonetics
7.3.1 Haemonetics Company Information
7.3.2 Haemonetics Introduction and Business Overview
7.3.3 Haemonetics Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Haemonetics Haemostasis Analyzers Product Offerings
7.3.5 Haemonetics Recent Development
7.4 Roche Diagnostics
7.4.1 Roche Diagnostics Company Information
7.4.2 Roche Diagnostics Introduction and Business Overview
7.4.3 Roche Diagnostics Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Roche Diagnostics Haemostasis Analyzers Product Offerings
7.4.5 Roche Diagnostics Recent Development
7.5 Abbott (Alere)
7.5.1 Abbott (Alere) Company Information
7.5.2 Abbott (Alere) Introduction and Business Overview
7.5.3 Abbott (Alere) Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Abbott (Alere) Haemostasis Analyzers Product Offerings
7.5.5 Abbott (Alere) Recent Development
7.6 Sysmex Corporation
7.6.1 Sysmex Corporation Company Information
7.6.2 Sysmex Corporation Introduction and Business Overview
7.6.3 Sysmex Corporation Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sysmex Corporation Haemostasis Analyzers Product Offerings
7.6.5 Sysmex Corporation Recent Development
7.7 Nihon Kohden
7.7.1 Nihon Kohden Company Information
7.7.2 Nihon Kohden Introduction and Business Overview
7.7.3 Nihon Kohden Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nihon Kohden Haemostasis Analyzers Product Offerings
7.7.5 Nihon Kohden Recent Development
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Information
7.8.2 Thermo Fisher Scientific Introduction and Business Overview
7.8.3 Thermo Fisher Scientific Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Thermo Fisher Scientific Haemostasis Analyzers Product Offerings
7.8.5 Thermo Fisher Scientific Recent Development
7.9 Siemens
7.9.1 Siemens Company Information
7.9.2 Siemens Introduction and Business Overview
7.9.3 Siemens Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Siemens Haemostasis Analyzers Product Offerings
7.9.5 Siemens Recent Development
7.10 Helena Laboratories
7.10.1 Helena Laboratories Company Information
7.10.2 Helena Laboratories Introduction and Business Overview
7.10.3 Helena Laboratories Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Helena Laboratories Haemostasis Analyzers Product Offerings
7.10.5 Helena Laboratories Recent Development
7.11 Instrumentation Laboratory (Werfen)
7.11.1 Instrumentation Laboratory (Werfen) Company Information
7.11.2 Instrumentation Laboratory (Werfen) Introduction and Business Overview
7.11.3 Instrumentation Laboratory (Werfen) Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Instrumentation Laboratory (Werfen) Haemostasis Analyzers Product Offerings
7.11.5 Instrumentation Laboratory (Werfen) Recent Development
7.12 Medcaptain Medical Technology
7.12.1 Medcaptain Medical Technology Company Information
7.12.2 Medcaptain Medical Technology Introduction and Business Overview
7.12.3 Medcaptain Medical Technology Haemostasis Analyzers Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Medcaptain Medical Technology Haemostasis Analyzers Product Offerings
7.12.5 Medcaptain Medical Technology Recent Development
8 Industry Chain Analysis
8.1 Haemostasis Analyzers Industrial Chain
8.2 Haemostasis Analyzers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Haemostasis Analyzers Sales Model
8.5.2 Sales Channel
8.5.3 Haemostasis Analyzers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Haemostasis Analyzers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
The global Haemostasis Analyzers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 138
USD 2900.00
(Single User License)
The global Haemostasis Analyzers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 151
USD 4900.00
(Single User License)
The global market for Haemostasis Analyzers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 111
USD 3950.00
(Single User License)
The global market for Haemostasis Analyzers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 99
USD 2900.00
(Single User License)
Haemostasis analyzers are instruments assisting the medical practitioners for treating patients with bleeding disorder or blood clotting.
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Haemostasis analyzers are instruments assisting the medical practitioners for treating patients with bleeding disorder or blood clotting.
Published Date: 2024-01-07
Pages: 102
USD 2900.00
(Single User License)
The global market for Haemostasis Analyzers was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
The global Haemostasis Analyzers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 138
The global Haemostasis Analyzers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 151
The global market for Haemostasis Analyzers was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 111
The global market for Haemostasis Analyzers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 99
Haemostasis analyzers are instruments assisting the medical practitioners for treating patients with bleeding disorder or blood clotting.
Published: 2024-04-12
Pages: 107
Haemostasis analyzers are instruments assisting the medical practitioners for treating patients with bleeding disorder or blood clotting.
Published: 2024-01-07
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now